Cureus,
Journal Year:
2024,
Volume and Issue:
unknown
Published: July 23, 2024
Mucormycosis
is
a
rare
yet
aggressive
fungal
infection.
Despite
its
rarity,
India
has
experienced
surge
in
cases
during
the
post-COVID-19
era.
The
high
mortality
rate
associated
with
this
infection
necessitates
early
diagnosis,
intervention,
and
treatment.
Typically,
it
observed
immunocompromised
patients,
where
disease
progresses
rapidly
leads
to
unfavorable
outcomes.
However,
occurrences
previously
healthy
individuals
are
not
uncommon.
Dengue
been
occasionally
mucormycosis
post-recovery
phase.
This
case
report
highlights
importance
of
heightened
clinical
suspicion
intervention
patients
recent
dengue
infections
chronic
sinus
conditions.
It
explores
potential
risk
factors,
such
as
dengue-related
immune
alterations,
environmental
exposures,
anatomical
alterations
that
may
contribute
development
otherwise
individuals.
Medical Mycology,
Journal Year:
2023,
Volume and Issue:
62(1)
Published: Dec. 21, 2023
Abstract
This
study
aimed
to
investigate
the
risk
factors
associated
with
intracranial
involvement
in
COVID-19-associated
mucormycosis
(CAM)
and
develop
a
nomogram
model
for
predicting
of
involvement,
specific
focus
on
perineural
spread.
An
ambispective
analysis
was
conducted
275
CAM
patients
who
received
comprehensive
treatment.
Univariable
multivariable
logistic
regression
analyses
were
performed
identify
independent
factors,
created
based
results
analysis.
The
performance
evaluated
using
receiver
operating
characteristic
(ROC)
curve,
discriminatory
capacity
assessed
area
under
curve
(AUC).
model's
calibration
through
Hosmer
Lemeshow
test.
In
results,
revealed
that
age
(OR:
1.23,
95%
CI
1.06–3.79),
HbA1c
7.168,
1.724–25.788),
spread
6.3,
1.281–19.874),
disease
stage
CAM.
developed
demonstrated
good
discriminative
an
AUC
0.821
(95%
0.713–0.909)
as
indicated
by
ROC
curve.
showed
well-calibrated,
test
yielded
P-value
0.992,
indicating
fit
model.
conclusion,
this
found
particularly
exhibits
spread,
which
is
predictive
factor
involvement.
A
incorporating
age,
HbA1c,
stage,
successfully
both
in-patient
out-patient
settings.
Journal of Clinical Medicine Research,
Journal Year:
2023,
Volume and Issue:
15(1), P. 31 - 37
Published: Jan. 1, 2023
Background:
Mucormycosis
necessitates
rapid
diagnosis
and
treatment.
Microscopy
culture
have
been
considered
the
gold
standard
for
but
both
take
time
of
3
-
5
days.
KOH
mount
is
another
method
fungal
identification
that
takes
1
2
h,
it
has
its
own
limitations.
This
study
evaluated
crush
smear
as
a
means
cytological
diagnosis.
Methods:
Biopsy
tissue
(pre-treatment)
from
clinically
suspicious
mucormycosis
patients
(n
=
52)
was
received
in
normal
saline
crush/imprint
smears
were
prepared;
remaining
processed
routine
biopsy
specimen.
After
initial
identification,
managed
according
to
clinical
protocol.
Random
post-therapeutic
samples
some
these
19)
also
obtained
again
cytologically.
Results:
Crush
showed
sensitivity/specificity
77.7%/75.0%
with
histopathology
72.2%/62.5%
culture,
respectively,
while
had
values
71.4%/70.5%
79.3%/69.5%
respectively.
Degenerative
morphological
characteristics
cellular
inflammatory
infiltrate
(predominantly
neutrophilic)
vicinity
hyphae
compared
pre-
post-treatment
groups,
we
found
statistically
significant
difference
(P
<
0.05)
between
them.
Conclusion:
Our
preliminary
results
suggest
cytology
simple,
rapid,
cost-effective
easily
available
diagnosing
mucormycosis.
Moreover,
demonstrated
alteration
hyphal
structure
accompanying
immune
cell
infiltration
which
may
provide
valuable
insights
into
mechanism
therapy/host
response
against
pathogen.
J
Clin
Med
Res.
2023;15(1):31-37
doi:
https://doi.org/10.14740/jocmr4835
Journal of Pharmacy And Bioallied Sciences,
Journal Year:
2023,
Volume and Issue:
15(Suppl 2), P. S1347 - S1350
Published: July 1, 2023
A
BSTRACT
The
current
study
aims
to
present
our
clinical
observations
and
experience
gathered
during
the
diagnosis,
presentation,
medical/surgical
treatment,
functional
prosthetic
rehabilitation
of
cases
rhino-orbital/cerebral
Mucormycosis
patients.
is
an
aggressive,
life-threatening
invasive
fungal
infection
that
occurs
in
people
who
are
immune-compromised.
rise
ROCM
second
wave
COVID-19
pandemic
India
suggests
a
more
effective
association
between
SARS-CoV-2
delta
variant.
treatment
strategy
for
early
diagnosis
which
critical
successful
outcome.
initial
step
reduce
or
remove
underlying
risk
factors
followed
by
surgical
excision
debridement
afflicted
tissues
supplemented
with
antifungal
medication.
first-line
Liposomal
Amphotericin
B.
Postsurgical
resection
defects
rehabilitated
either
removable
partial
prosthesis
(obturators)
fixed
zygomatic
implant/patient-specific
implant
supported
prosthesis.
Management
requires
multidisciplinary
approach.
This
case
series
highlights
detailed
medical,
surgical,
management
modalities
adopted
team
managing
such
dreaded
disease
may
be
used
as
tool
formulation
standardized
prevention
management/treatment/rehabilitation
protocols
future
so
morbidity
mortality
reduced
endemic
outbreak
could
averted.
Cureus,
Journal Year:
2024,
Volume and Issue:
unknown
Published: July 23, 2024
Mucormycosis
is
a
rare
yet
aggressive
fungal
infection.
Despite
its
rarity,
India
has
experienced
surge
in
cases
during
the
post-COVID-19
era.
The
high
mortality
rate
associated
with
this
infection
necessitates
early
diagnosis,
intervention,
and
treatment.
Typically,
it
observed
immunocompromised
patients,
where
disease
progresses
rapidly
leads
to
unfavorable
outcomes.
However,
occurrences
previously
healthy
individuals
are
not
uncommon.
Dengue
been
occasionally
mucormycosis
post-recovery
phase.
This
case
report
highlights
importance
of
heightened
clinical
suspicion
intervention
patients
recent
dengue
infections
chronic
sinus
conditions.
It
explores
potential
risk
factors,
such
as
dengue-related
immune
alterations,
environmental
exposures,
anatomical
alterations
that
may
contribute
development
otherwise
individuals.